Study guide

About the CARN-AP Examination: Blueprint, Scoring & Eligibility

Certified Addictions Registered Nurse - Advanced Practice CARN-AP

Track your progress as you read

Finished sections get a check mark.

1 Introduction: The CARN-AP Examination & Foundations of Advanced Addictions Practice

About the CARN-AP Examination: Blueprint, Scoring & Eligibility The Neurobiology of Addiction: Binge, Withdrawal & Preoccupation Screening, SBIRT & the ASAM Criteria Levels of Care

2 Chapter 1: Opioid Use Disorder: Assessment, Overdose Response & Methadone Maintenance

1.1 OUD Assessment, DSM-5-TR Diagnostic Criteria, and Clinical Opiate Withdrawal Scale (COWS) 1.2 Methadone Pharmacology, OTP Federal Regulations, QTc Prolongation & CYP450 Interactions 1.3 Opioid Overdose Assessment, Harm Reduction, Naloxone Formulations & Nalmefene

3 Chapter 2: Buprenorphine Protocols, Long-Acting Injectables & Naltrexone

2.1 Buprenorphine Pharmacology, Standard Office/Home Induction & Precipitated Withdrawal Management 2.2 Low-Dose Micro-Induction (Bernese Method) & Fentanyl Transition Strategies 2.3 Long-Acting Injectable Buprenorphine (Sublocade, Brixadi) & Extended-Release Naltrexone (Vivitrol)

4 Chapter 3: Alcohol Use Disorder: Neurobiology, Assessment & Acute Withdrawal

3.1 AUD Neurobiology, Epidemiology, Screening Instruments (AUDIT, AUDIT-C, CAGE) & Laboratory Biomarkers 3.2 Alcohol Withdrawal Syndrome, CIWA-Ar Protocol, Symptom-Triggered Benzodiazepine Regimens & Delirium Tremens 3.3 Wernicke-Korsakoff Syndrome, High-Dose Parenteral Thiamine Protocols & Acute Medical Complications

5 Chapter 4: Medications for Alcohol Use Disorder (MAUD)

4.1 Oral and Injectable Naltrexone for AUD: Mechanism, Prescribing Protocols & Clinical Efficacy 4.2 Acamprosate Calcium: NMDA Modulation, Renal Dosing Parameters & Abstinence Maintenance 4.3 Disulfiram and Second-Line / Off-Label MAUDs: Topiramate, Gabapentin & Baclofen

6 Chapter 5: Stimulant, Sedative-Hypnotic & Synthetic Substance Use Disorders

5.1 Stimulant Use Disorder (Cocaine & Methamphetamine): Neurotoxicity, Medical Emergencies & Evidence-Based Interventions 5.2 Sedative, Hypnotic, and Anxiolytic Disorders: Dependence Physiology, Risks & Outpatient Tapering Protocols 5.3 Emerging Synthetic Drugs: Fentanyl Analogues, Synthetic Cathinones, Cannabinoids & Xylazine-Associated Necrotic Wounds

7 Chapter 6: Tobacco and Cannabis Use Disorders: Evidence-Based Pharmacotherapy & Interventions

6.1 Tobacco Use Disorder & Nicotine Dependence: Dual NRT, Varenicline & Bupropion Prescribing Protocols 6.2 Cannabis Use Disorder, Synthetic Cannabinoids & Cannabinoid Hyperemesis Syndrome 6.3 Behavioral Therapies in Substance Use: Motivational Interviewing, CBT & Contingency Management

8 Chapter 7: Psychiatric Differential Diagnosis & Medical Mimics in Addictions

7.1 Diagnostic Formulation: Primary vs. Substance-Induced Psychiatric Disorders & The 30-Day Rule 7.2 Endocrine, Neurological, and Metabolic Mimics of Substance Intoxication and Withdrawal 7.3 Decisional Capacity, Competency, and Involuntary Commitment in Acute Addiction Practice

9 Chapter 8: Co-Occurring Psychiatric Disorders: Integrated Treatment Planning

8.1 Integrated Dual Diagnosis Treatment (IDDT) Framework & High-Prevalence Mood / Anxiety Co-Occurring Disorders 8.2 Complex Severe Mental Illness: Psychotic Disorders, Bipolar Disorder & Borderline Personality in Addictions 8.3 Trauma-Informed Care, PTSD, and Addictions: Evidence-Based Integrated Psychotherapy

10 Chapter 9: Pain Management in Substance Use Disorders & CDC 2022 Guidelines

9.1 CDC 2022 Clinical Practice Guideline for Prescribing Opioids for Chronic Pain: Individualized Assessment vs. Hard Caps 9.2 Multimodal Non-Opioid Pharmacotherapy, Interventional Modalities & Non-Pharmacological Strategies 9.3 Acute Pain Management in Patients on Maintenance MOUD (Methadone, Buprenorphine, Naltrexone)

11 Chapter 10: Perinatal Substance Use, Neonatal Abstinence & Infectious Complications

10.1 Perinatal Substance Use Disorder: ACOG/ASAM Guidelines, MOTHER Trial & Maintenance MOUD 10.2 Neonatal Abstinence Syndrome (NAS/NOWS): Finnegan Scoring vs. Eat, Sleep, Console (ESC) & Breastfeeding 10.3 Infectious Complications in People Who Inject Drugs: Viral Hepatitis, HIV, Endocarditis & PrEP/PEP

12 Chapter 11: Federal Regulations, Confidentiality & Controlled Substance Prescribing

11.1 Controlled Substances Act, DEA Registration, Schedule Classifications & MAT Act of 2023 11.2 Confidentiality of Substance Use Disorder Patient Records: 42 CFR Part 2 (2024 Final Rule) & HIPAA Harmonization 11.3 Prescription Drug Monitoring Programs (PDMP) & Urine Drug Testing (UDT) Interpretation

13 Chapter 12: APRN Scope of Practice, Ethical Foundations, Harm Reduction & Research Literacy

12.1 APRN Scope of Practice, Prescriptive Authority & Collaborative Practice Regulations 12.2 Ethical Dilemmas in Addictions Nursing: Stigma, Autonomy, Justice, and Maternal/Fetal Rights 12.3 Harm Reduction Philosophy, Syringe Service Programs, Drug Checking & Overdose Prevention 12.4 Landmark Clinical Trials & Research Literacy in Addictions Medicine

14 Chapter 13: Stimulant Use Disorder in Depth — Methamphetamine, Withdrawal, Treatment & Harm Reduction

13.1 Methamphetamine Use Disorder: Pharmacology, Medical & Psychiatric Sequelae 13.2 Stimulant Withdrawal, Craving & Contingency Management 13.3 Pharmacotherapy Research for Stimulant Use Disorder 13.4 Stimulant Harm Reduction, Overamping & Patient Education

15 Chapter 14: Medical Consequences of Alcohol Use — Liver, Heart, Cancer & Nutrition

14.1 Alcohol-Associated Liver Disease: Staging, Scoring & Management 14.2 Cardiovascular, Oncologic & Nutritional Consequences of Alcohol

16 Chapter 15: Brief Intervention, Drinking Goals & Recovery Support in Alcohol Use Disorder

15.1 Brief Intervention, Drinking Goals & Shared Decision Making in AUD 15.2 Relapse Prevention, Mutual-Help Programs & Recovery Support

17 Chapter 16: Tobacco Use Disorder in Depth — Neurobiology, Assessment & Special Populations

16.1 Nicotine Neurobiology, Epidemiology & the Tobacco Product Landscape 16.2 Tobacco Assessment & Behavioral Treatment: 5 A's, Quitlines & Incentives 16.3 Tobacco Treatment in Special Populations & Co-Occurring Disorders

18 Chapter 17: Cannabis Use Disorder in Depth — Products, Treatment & Policy

17.1 Cannabinoid Pharmacology, Potency & the Modern Product Landscape 17.2 Cannabis Use Disorder: Epidemiology, Assessment & Treatment Evidence 17.3 Medical Cannabis, Legalization Policy, Adolescent Risk & Patient Education

19 Chapter 18: Other Use Disorders — Inhalants, Hallucinogens, Process Addictions & Prescription/OTC Misuse

18.1 Inhalant Use Disorder: Volatile Solvents, Nitrous Oxide & Alkyl Nitrites 18.2 Hallucinogens & Dissociatives: Classic Psychedelics, PCP, Ketamine & HPPD 18.3 Process (Behavioral) Addictions: Gambling Disorder, Gaming & Compulsive Behaviors 18.4 Prescription & Over-the-Counter Substance Misuse: Opioids, Stimulants, Kratom & DXM

20 Chapter 19: Educating Patients, Families & the Public (CARN-AP Activity Area III)

19.1 Designing Health Teaching: Literacy, Readiness, Culture & Teach-Back 19.2 Medication Education, Informed Consent & Informed Refusal 19.3 Family & Support-System Education: CRAFT, Al-Anon & Overdose Prevention Teaching 19.4 Public, Professional & Anticipatory Guidance: Prevention and Advocacy Teaching

21 Chapter 20: Consultation, Collaboration & Care Coordination (CARN-AP Activity Area IV)

20.1 The APRN Consultation Process & Communicating Recommendations 20.2 Interprofessional Collaboration, Care Coordination & Transitions of Care 20.3 Community Resources, Systems Navigation & Collaborative Documentation

22 Chapter 21: Quality Improvement, Evidence & Leadership in Addictions Nursing (CARN-AP Activity Area V)

21.1 Outcome Measurement & Continuous Quality Improvement in Addictions Care 21.2 Policy Advocacy, Leadership & the Determinants of Addiction

About the CARN-AP Examination: Blueprint, Scoring & Eligibility

Key Takeaways Explain This Topic AI

The CARN-AP examination contains 150 multiple-choice items, about 25 of which are unscored pilot items, and candidates are allowed 4 hours to complete it.

A passing score requires answering 77% of the CARN-AP test items correctly; the standard is set by the Angoff procedure, not by ranking candidates against one another.

The blueprint is a two-dimensional grid: seven Patient Problem categories (opioid 24%, alcohol 24%, stimulant 15%, co-occurring/comorbid 13%, other use disorders 9%, tobacco 8%, cannabis 7%) crossed with five CARN-AP Activity areas.

Half the exam is non-prescribing work: Educate carries 25% of items and Consult/Collaborate carries 10%, more than the 16% assigned to pharmacological prescribing.

Eligibility requires an unrestricted RN license, a master's degree or higher in nursing, 2,000 hours of advanced addictions practice (including 500 supervised direct-contact hours within 4 years), 1,500 APRN addictions hours within 3 years, and 45 addictions contact hours within 3 years.

Last updated: September 2026

About the CARN-AP Examination: Blueprint, Scoring & Eligibility

Quick Answer: The Certified Addictions Registered Nurse – Advanced Practice ( CARN-AP ) examination is a 150-item , 4-hour , single-best-answer computer-based test owned by the Addictions Nursing Certification Board (ANCB) and delivered by the Center for Nursing Education and Testing (C-NET) through PSI testing centers. About 25 of the 150 items are unscored pilot questions . The passing standard is 77% of test items answered correctly , established by the Angoff procedure — a criterion-referenced method in which subject-matter experts judge item difficulty in advance. Certification lasts four years . The 2026 blueprint is a grid of seven Patient Problem categories by five CARN-AP Activity areas .

1. Examination Logistics

  • Element Current Specification
  • Credentialing body Addictions Nursing Certification Board (ANCB)
  • Testing service Center for Nursing Education and Testing (C-NET); delivered at PSI test centers
  • Items 150 multiple-choice, single-best-answer (about 25 unscored pilot items)
  • Testing time 4 hours
  • Passing standard 77% of test items answered correctly (Angoff-based, criterion-referenced)
  • Score reporting Immediate at the test center; failing candidates also receive sub-scores by major content area
  • Guessing penalty None — answer every item
  • Calculator Not required; examination questions do not depend on calculation

Scheduling Year-round; a 90-day testing window opens after registration, extendable once by up to 90 days for a fee

  • Certification period 4 years
  • Fee 400 USD standard; 350 USD with proof of IntNSA USA, ASAN, or NOVA membership

Exam trap: a criterion-referenced standard means your result never depends on how other candidates performed. There is no curve and no fixed pass rate. Two candidates who each answer 77% correctly both pass, even if every other examinee that month outscored them.

Why the pilot items matter

Roughly one in six items you see is being field-tested and will not count. You cannot identify them, and they are distributed throughout the test. The practical consequence is that an item that feels bizarre, ambiguous, or unlike anything in the literature is often a pilot item — flag it, make a reasoned choice, and move on rather than spending five minutes that a scored item needs.

2. Eligibility Criteria

ANCB requires all of the following before an application is accepted:

Licensure: a current, full, unrestricted RN license obtained by passing the NCLEX, or a license verified for equivalency by CGFNS, WES, or ERES. A candidate licensed in more than one jurisdiction must hold a license in every jurisdiction where they practice.

Education: a master's degree or higher in nursing, documented by diploma or transcript showing name, conferred degree, and graduation date.

Clinical experience: attestation to a minimum of 2,000 hours (about one year) of advanced clinical practice in addictions nursing. This must include 500 hours of supervised, direct client contact in advanced clinical practice within the last 4 years , plus 1,500 additional hours of APRN addictions nursing experience within the last 3 years .

Continuing education: 45 contact hours of approved continuing education in addictions within the last 3 years , with at least 51% specific to addictions nursing .

ANCB also operates an alternative-to-discipline policy . A nurse in recovery whose license is restricted but who is in full compliance with a monitoring program may sit for the examination if the monitoring program submits a letter verifying active licensure, compliance, and support for examination eligibility. A nurse who surrendered a license or violated a monitoring agreement is ineligible.

3. The Two-Dimensional Blueprint

Every item on the CARN-AP is coded to one Patient Problem and one CARN-AP Activity . Studying only substances leaves half the blueprint untouched.

Dimension 1 — Patient Problem

  • Category Weight Approximate items
  • A. Opioid use disorder 24% 35–37
  • B. Alcohol use disorder 24% 35–37
  • C. Stimulant use disorder 15% 22–24

D. Co-occurring psychiatric (mental health) or comorbid medical conditions, e.g., infectious diseases 13% 19–21

E. Other use disorders, e.g., prescription drugs, inhalants, hallucinogens, designer drugs, process addictions 9% 13–15

  • F. Tobacco use disorder 8% 11–13
  • G. Cannabis use disorder 7% 10–12
  • Dimension 2 — CARN-AP Activity

Area Description Weight Items

I Screen, assess and diagnose the processes and complications of substance-related and addictive disorders 30% 44–46

II-A Prescribe pharmacological interventions: evaluate, prescribe and manage agents accounting for side effects, adverse reactions, efficacy and desired outcomes 16% 24–25

  • II-B Prescribe non-pharmacological interventions using shared decision making 14% 21–22
  • III Educate patients, families (support systems), other health professionals and the public 25% 37–38
  • IV Consult, collaborate and coordinate care with health professionals and peer specialists 10% 14–15

V Incorporate ethical principles and evidence-based practice to promote clinical excellence, optimal outcomes, continuous quality improvement and policy advocacy 5% 7–8

The single most useful planning insight

Education (25%) outweighs pharmacological prescribing (16%). A candidate who memorizes every buprenorphine microdosing schedule but cannot select the right teach-back strategy for a patient with limited health literacy will leave 37 items on the table. Combine the two dimensions when you study: for each substance, ask not only what do I prescribe? but what do I teach the patient, what do I teach the family, and whom do I consult?

4. How the Blueprint Was Built

The exam rests on a Role Delineation Study (practice analysis) repeated roughly every five years. The 2025 study surveyed addictions APRNs nationally; 108 CARN-APs responded from 31 states. Respondents rated 73 activity statements on both frequency and importance, with importance double-weighted to produce an index score; statements scoring below an index of 7.5 were removed. Fifty-three knowledge, skill and ability statements were rated for importance.

Two findings from that study explain the current weights:

Respondents reported spending a mean of 32.65% of practice time with patients who have opioid use disorder and 23.66% with alcohol use disorder — the two categories held at 24% each. Time spent with stimulant-using patients rose from 9.69% to 15.74% , matching the 15% stimulant weight.

The highest-rated knowledge statement was communication skills (mean 3.93 of 4), ahead of knowledge of the process of substance use disorder and pharmacology. The lowest-rated were group therapy skills, research skills, and policy development — which is precisely why Area V carries only 5%.

5. A Study Plan That Matches the Grid

Anchor on the two 24% categories. Opioids and alcohol together are 48% of the exam — roughly 72 items. Assume you must be near-perfect there.

Do not skip the small categories. Tobacco (8%), cannabis (7%) and “other use disorders” (9%) total 24% — about 36 items, more than the entire stimulant category. Inhalants, hallucinogens and process addictions live in that 9% and are the most commonly neglected content on the whole blueprint.

Rehearse the activity verbs. For each substance, prepare one assessment answer, one pharmacological answer, one non-pharmacological answer, one teaching answer, and one consultation answer.

Expect situational sets. ANCB states that some items appear as a scenario followed by several linked questions. Read the stem once carefully rather than re-reading for each linked item.

Practice at test pace. 150 items in 240 minutes is 96 seconds per item — generous by nursing-certification standards, which means the exam rewards careful reading rather than speed.